SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The decline in XRP is driven by the U.S. Senate's failure to advance the Crypto Clarity Act, which traders view as a major setback for short-term regulatory progress. While many express frustration and blame political deadlock for the market volatility, others remain optimistic about the asset's long-term utility and view the price drop as a buying opportunity.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and impending clinical data following the company's recent participation in healthcare conferences, which highlighted strong Amtagvi commercial momentum and a robust, de-risked solid tumor pipeline. Sentiment is buoyed by anticipation for upcoming Phase 2 NSCLC trial results, with many traders viewing the stock's recent price action as institutional accumulation ahead of major catalysts.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is receiving attention primarily due to recent open-market insider purchases by the CEO, which traders are debating as either a signal of genuine high-conviction in the company's future or a symbolic gesture to bolster sentiment. Meanwhile, the community is closely tracking the brand's competitive position and recent marketing initiatives, such as its new sponsorship of ESPN's College GameDay.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

The community is debating the failure of the Digital Asset Market CLARITY Act to pass a Senate procedural vote, with many traders viewing the event as a catalyst for increased volatility and potential downside. While some investors interpret the legislative deadlock as a bearish signal for the broader crypto market, others maintain that Bitcoin's long-term utility and global adoption remain intact independent of U.S. regulatory outcomes.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is facing persistent downward pressure as investors weigh macroeconomic headwinds, including high interest rates, inflationary concerns, and geopolitical instability, against a long-term thesis centered on CEO Brad Jacobs' M&A strategy. While some investors remain optimistic about the company's long-term growth potential and recent executive appointments, others express frustration over continued share price depreciation, concerns regarding dilution, and the lack of a near-term catalyst.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant bearish sentiment, with traders debating whether the stock's recent decline is driven by broader market pressure, ongoing short selling, or concerns over share dilution following the finalization of the LivePerson acquisition. While many investors express frustration over the sustained downward price trend, others maintain a long-term bullish outlook, pointing to the company's completed merger, new CFO appointment, and potential for future revenue growth through enterprise AI integration.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase shares declined as the U.S. Senate failed to advance the CLARITY Act, a crypto market structure bill that traders had hoped would provide regulatory certainty. The outcome, compounded by broad volatility in Bitcoin and broader crypto-related equities, fueled bearish sentiment as many investors view the legislative impasse as a significant setback for near-term industry growth.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The market is consolidating as investors remain cautious ahead of a highly anticipated Federal Reserve interest rate decision. Traders are divided on the potential impact, with many expressing concern over high inflation, rising bond yields, and the economic fallout from ongoing geopolitical tensions.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the release of positive final Phase 3 data for its kidney disease treatment, Trutakna, which showed significant reductions in disease progression and stabilized kidney function. While many traders are bullish on the data and the potential for a short squeeze or buyout, others express frustration over intraday price volatility and note competition from other therapies in the IgAN market.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt is facing downward pressure amid broader cryptocurrency market volatility and investor frustration over a lack of major corporate catalysts. Discussion is largely dominated by concerns regarding the stock's continued correlation with Bitcoin and the absence of positive news to sustain momentum, leading to a split in sentiment between those betting on the company's long-term infrastructure pivot and those discouraged by persistent price declines.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALMS $SRLN https://finance.yahoo.com/news/acelyrin-alumis-reaffirm-strategic-financial-140100431.html

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN) and Alumis Inc. (Nasdaq: ALMS) today reaffirmed their commitment to merge in an all-stock transaction, which will create a leading clinical stage biopharma company in immune-mediated diseases.

Yahoo Finance

ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

StockTwits Web

Alumis Inc.

SPDR Blackstone Senior Loan ETF

Rob Lewis

@IN0V8 merger. Got it. Why is this pumping a month after PR? Isn’t that supposed to happen before the PR?

throwaway6969

StockTwits for iOS

 merger. Got it. Why is this pumping a month after PR? Isn’t that supposed to happen before the PR?